Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co IPO Roadshow Transcript

Jun 08, 2020 / NTS GMT
Geoff McDonough
Generation Bio Co. - President & CEO

Welcome and thank you for joining this preview of our work at Generation Bio ahead of our public offering. I'm Geoff McDonough, CEO of Generation Bio. I'm really excited to share our vision around creating a new class of gene therapy, durable, re-dosable and scalable for millions of patients living with rare and prevalent diseases.

First-generation gene therapy has made strides towards durability but true redosing and scale are unprecedented features. And as I said, I'm very excited to walk you through what has led us to be able to offer these features and where we believe it will take us as a company.

In this presentation, I'm going to give you a comprehensive overview and introduction to the company, walk you through in detail the scientific elements of our platform, and introduce you to our portfolio before summarizing the events that we see unfolding on our journey towards building a major biotech innovator. The ambition to create a new class of nonviral gene therapy requires a unique combination of breakthrough technologies in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot